These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15485599)

  • 1. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Curr Cardiol Rep; 2004 Nov; 6(6):409-15. PubMed ID: 15485599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.
    Liebson PR; Serry RD
    Curr Hypertens Rep; 2000 Jun; 2(3):260-70. PubMed ID: 10981159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
    Subramaniam V; Lip GY
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
    Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early target organ damage and its reversibility: the heart.
    Rosei EA; Muiesan ML
    Clin Exp Hypertens; 2004; 26(7-8):673-87. PubMed ID: 15702622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.
    Moser M; Hebert PR
    J Am Coll Cardiol; 1996 Apr; 27(5):1214-8. PubMed ID: 8609345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy.
    Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY
    J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and reduction of left ventricular hypertrophy in the elderly.
    Lavie CJ; Milani RV; Messerli FH
    Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Prevention of Hypertensive Heart Failure.
    Kalogeropoulos AP; Goulbourne C; Butler J
    Heart Fail Clin; 2019 Oct; 15(4):435-445. PubMed ID: 31472879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cardiac effects of antihypertensive agents.
    Agabiti-Rosei E
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S42-8. PubMed ID: 7609505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.